Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Free Report) has received an average recommendation of “Hold” from the five ratings firms that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company. […]

Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eight brokerages that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, six have issued a buy rating and one has assigned a strong buy […]